Clinical trials
Phase 1/2 Scleroderma, Systemic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 3 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stanford University | 2 |
| University of California, Los Angeles | 2 |
| Boston University | 1 |
| Fate Therapeutics | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Genzyme, a Sanofi Company | 1 |
| Kyverna Therapeutics | 1 |
| M.D. Anderson Cancer Center | 1 |
| Nkarta, Inc. | 1 |
| Prism Pharma Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 14 |
| Scleroderma, Diffuse | 10 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2 |
| Arthritis, Rheumatoid | 2 |
| Autoimmune Diseases | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Myositis | 2 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Dermatomyositis | 1 |
| Graft vs Host Disease | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.